MGD020 / MacroGenics - LARVOL DELTA

The DART DELIVER-02 Study (clinicaltrials.gov) - P1 | N=24 | Recruiting | Sponsor: University of North Carolina, Chapel Hill

New P1 trial • Human Immunodeficiency Virus • Infectious Disease

A Study of MGD020 Alone or Combined With MGD014 in Persons With HIV-1 on Antiretroviral Therapy (clinicaltrials.gov) - P1 | N=24 | Completed | Sponsor: MacroGenics | Active, not recruiting ➔ Completed | N=54 ➔ 24

Combination therapy • Enrollment change • Trial completion • Human Immunodeficiency Virus • Infectious Disease • CD4

A Study of MGD020 Alone or Combined With MGD014 in Persons With HIV-1 on Antiretroviral Therapy (clinicaltrials.gov) - P1 | N=54 | Active, not recruiting | Sponsor: MacroGenics | Recruiting ➔ Active, not recruiting

Combination therapy • Enrollment closed • Human Immunodeficiency Virus • Infectious Disease • CD4

A Study of MGD020 Alone or Combined With MGD014 in Persons With HIV-1 on Antiretroviral Therapy (clinicaltrials.gov) - P1 | N=54 | Recruiting | Sponsor: MacroGenics | Trial completion date: Jul 2023 ➔ Mar 2024 | Trial primary completion date: Jul 2023 ➔ Mar 2024

Combination therapy • Trial completion date • Trial primary completion date • Human Immunodeficiency Virus • Infectious Disease • CD4 • IL10 • IL2 • IL5 • IL6

A Study of MGD020 Alone or Combined With MGD014 in Persons With HIV-1 on Antiretroviral Therapy (clinicaltrials.gov) - P1 | N=54 | Recruiting | Sponsor: MacroGenics | Not yet recruiting ➔ Recruiting

Combination therapy • Enrollment open • Human Immunodeficiency Virus • Immunology • Infectious Disease • CD4 • IL10 • IL2 • IL5 • IL6